Harvard Apparatus Regenerative Technology Inc. announced that it has entered into Securities Purchase Agreements with certain investors to issue an aggregate of 367,767 shares of common stock at a purchase price of $4.03 per share for the gross proceeds of $1,482,101.01 on April 15, 2024. The shares are issued without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated under and/or Regulation D thereunder.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -14.18% | -0.86% | -53.91% |
1st Jan change | Capi. | |
---|---|---|
-53.91% | 32.92M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.34% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding